Literature DB >> 34309787

Is double-seropositive myasthenia gravis a distinct subtype?

Vaibhav Seth1, Suman Kushwaha2, Prateek Bapat3, KiranGowda Rajashekar3, Deepti Grover3.   

Abstract

Entities:  

Year:  2021        PMID： 34309787     DOI： 10.1007/s13760-021-01759-2

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN： 0300-9009            Impact factor:   2.396


× No keyword cloud information.
  6 in total

1.  Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.

Authors:  Michael K Hehir; Lisa D Hobson-Webb; Michael Benatar; Carolina Barnett; Nicholas J Silvestri; James F Howard; Diantha Howard; Amy Visser; Brian A Crum; Richard Nowak; Rachel Beekman; Aditya Kumar; Katherine Ruzhansky; I-Hweii Amy Chen; Michael T Pulley; Shannon M LaBoy; Melissa A Fellman; Shane M Greene; Mamatha Pasnoor; Ted M Burns
Journal:  Neurology       Date:  2017-08-11       Impact factor: 9.910

2.  AChR-myasthenia gravis switching to double-seropositive several years after the onset.

Authors:  Vasiliki Zouvelou; Paraskevi Zisimopoulou; Erasmia Psimenou; Eirini Matsigkou; Eleftherios Stamboulis; Socrates J Tzartos
Journal:  J Neuroimmunol       Date:  2013-12-22       Impact factor: 3.478

Review 3.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

4.  Clinical aspects of MuSK antibody positive seronegative MG.

Authors:  D B Sanders; K El-Salem; J M Massey; J McConville; A Vincent
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

Review 5.  AChRAb and MuSKAb double-seropositive myasthenia gravis: a distinct subtype?

Authors:  Jieni Zhang; Yin Chen; Jiaxin Chen; Xin Huang; Haiyan Wang; Yan Li; Weibin Liu; Huiyu Feng
Journal:  Neurol Sci       Date:  2021-01-12       Impact factor: 3.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.